Special Issue on the Promise of Psychedelic Pharmacology in Neuropsychiatric Drug Development
Pharmacology Research & Perspectives · 2026-08 · 14 (4)
DOI: 10.1002/prp2.70309 ↗Kurz gefasst
Editorial in der Zeitschrift Pharmacology Research & Perspectives, online erschienen am 29.07.2026. Verfasst von Andreas Halman und 1 weiteren Autor:innen. Beteiligte Einrichtung: Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
- Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
- Cancer Therapies, Stem Cell Medicine, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
- Pharmacology Research & Perspectives Editorial Board, New Castle, New South Wales, Australia.
ORCID-Profile: Andreas Halman
Zitieren
APA
Halman, A., & Corriden, R. (2026). Special Issue on the Promise of Psychedelic Pharmacology in Neuropsychiatric Drug Development. Pharmacology Research & Perspectives, 14(4). https://doi.org/10.1002/prp2.70309
Vancouver
Halman A, Corriden R. Special Issue on the Promise of Psychedelic Pharmacology in Neuropsychiatric Drug Development. Pharmacology Research & Perspectives. 2026;14(4). doi:10.1002/prp2.70309
BibTeX
@article{Halman2026,
author = {Halman, Andreas and Corriden, Ross},
title = {Special Issue on the Promise of Psychedelic Pharmacology in Neuropsychiatric Drug Development},
journal = {Pharmacology Research & Perspectives},
year = {2026},
volume = {14},
number = {4},
doi = {10.1002/prp2.70309}
}
EUVIMED